Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Stock Option Activity (Detail)

v3.23.1
Stockholders' Equity - Stock Option Activity (Detail) - $ / shares
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Equity [Abstract]    
Shares, Outstanding at beginning of period 1,263,340  
Shares, Granted 0  
Shares, Forfeited (538,756)  
Shares, Outstanding at end of period 724,584 1,263,340
Shares, Vested and expected to vest at end of period 703,751  
Shares, Options exercisable at end of period 397,083  
Weighted Average Exercise Price, Outstanding at beginning of period $ 1.40  
Weighted Average Exercise Price, Forfeited 1.67  
Weighted Average Exercise Price, Outstanding at end of period 1.21 $ 1.40
Weighted Average Exercise Price, Vested and expected to vest at end of period 1.20  
Weighted Average Exercise Price, Options exercisable at end of period $ 1.27  
Weighted Average Remaining Contractual Term, Outstanding at beginning of period 8 years 18 days 8 years 8 months 1 day
Weighted Average Remaining Contractual Term, Vested and expected to vest at end of period 8 years 14 days  
Weighted Average Remaining Contractual Term, Options exercisable at end of period 7 years 10 months 2 days